iPhone | iPad
Android
Huawei
Other requests include residents seeking assistance with cleaning mud accumulation, restoring damaged furniture
KT APPDOWNLOAD
Covid-19: Philippines approves Pfizer vaccine for emergency use
A man wearing a face mask and a face shield passes by a mural dedicated to frontline workers in Manila. — Reuters
Manila - The country is due to receive the first batch of Pfizer-BioNTech’s vaccines in the first quarter through the Covax facility
The Philippines’ Food and Drug Administration has authorised for emergency use the Covid-19 vaccine developed by Pfizer and BioNTech, the first to be approved in the country.
FDA head Rolando Enrique Domingo said the Pfizer-BioNTech vaccine, which has shown a 95 per cent success rate, could be effective in preventing Covid-19, with which nearly half a million people in the Philippines have been infected.
“The benefit of using vaccine outweighs the known and potential risks,” he told a briefing, adding “no specific safety concerns were identified”.
The Philippines has had difficulties convincing the public to use vaccines in recent years and an opinion poll last week showed less than a third of people were willing to get inoculated against the coronavirus, with concerns over safety.
It is due to receive the first batch of Pfizer-BioNTech’s vaccines in the first quarter through the Covax facility, on top of a deal it is negotiating directly with the vaccine maker.
Domingo also said China’s Sinovac Biotech on Wednesday submitted its emergency use authorisation application.
That followed the release of late-stage trial data in Brazil that showed efficacy at just 50.4 per cent. The Philippines has secured 25 million doses of Sinovac’s CoronaVac, with the first 50,000 to arrive in February.
President Rodrigo Duterte defended the government’s purchase of CoronaVac, saying on Wednesday night that it was as good as the shots developed by Americans and Europeans.
The Philippines has trailed regional peers in securing vaccines, with which it hopes this year to inoculate 70 million people, or two-thirds of its population.
Carlito Galvez, who handles the vaccine procurement for the government, said it has now firmed-up supply deals with Novavax , Moderna, AstraZeneca, Johnson & Johnson and Russia’s Gamaleya Institute.
AstraZeneca and Gamaleya have pending emergency use applications with the FDA.
More news from
Many students wade through waist-deep water to head to neighbour's house for online classes
Hospitals brace for uptick in typhoid and bacterial infections; and mosquito- and fly-borne diseases like dengue
With 30% of their inventory damaged, owners of Preloved Books now face the daunting task of rebuilding from scratch
Five-time champions hold their nerve to claim victory by nine runs in the final over at Chandigarh
Natasha Abbas is a British civil engineer who co-founded North 51, a project management consultancy in Dubai
People who are assessing your qualifications can quickly tell the difference between an authentic life narrative and a third-party account
Arab-Canadian public speaking coach and author of The Million Dollar Speaker Maher Elusini on how to make your speech command value for time and money
